INTRAVENOUS IMMUNOGLOBULINS: MECHANISMS OF THERAPEUTIC EFFECTS

Intravenous immunoglobulins (IVIG) are currently the most widely used immunobiological drug derived from donor blood. The IVIG preparations contain antibodies, mostly, of IgG class, obtained from plasma pools of 3,000 to 15,000 donors (over 1000 donors per lot, according to international standards a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: V. A. Lazanovich, E. V. Prosekova
Formato: article
Lenguaje:RU
Publicado: SPb RAACI 2014
Materias:
Acceso en línea:https://doaj.org/article/8ed4342c9bdc4d5fa4a83c4ced64c76c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8ed4342c9bdc4d5fa4a83c4ced64c76c
record_format dspace
spelling oai:doaj.org-article:8ed4342c9bdc4d5fa4a83c4ced64c76c2021-11-18T08:03:43ZINTRAVENOUS IMMUNOGLOBULINS: MECHANISMS OF THERAPEUTIC EFFECTS1563-06252313-741X10.15789/1563-0625-2014-4-311-322https://doaj.org/article/8ed4342c9bdc4d5fa4a83c4ced64c76c2014-08-01T00:00:00Zhttps://www.mimmun.ru/mimmun/article/view/697https://doaj.org/toc/1563-0625https://doaj.org/toc/2313-741XIntravenous immunoglobulins (IVIG) are currently the most widely used immunobiological drug derived from donor blood. The IVIG preparations contain antibodies, mostly, of IgG class, obtained from plasma pools of 3,000 to 15,000 donors (over 1000 donors per lot, according to international standards and guidelines), being used for treatment of various diseases over four last decades. Initially, IVIG application wasaimed for immune support only in primary immunodeficiency states. However, recent clinical and experimental data show effectiveness of the IVIG in systemic and autoimmune diseases, immune-associated infertility and miscarriage. As well as in translantology, hematology and other fields of medicine. Their efficiency is associated with immunomodulatory effects. There is a growing number of publications bearing on this subject and elucidating possible mechanisms of therapeutic effects of IVIG, which are based on the latest basic and clinical research findings in this area. At the same time, much issues remain unclear and contradictory, and some data are mutually exclusive, thus prompting further studies and trials of IVIG preparations. The aim of this article is to summarize the known basic mechanisms of therapeutic effects, main results of recent research in this area,and potential clinical applications of IVIG in future.V. A. LazanovichE. V. ProsekovaSPb RAACIarticleintravenous immunoglobulintherapymechanismImmunologic diseases. AllergyRC581-607RUMedicinskaâ Immunologiâ, Vol 16, Iss 4, Pp 311-322 (2014)
institution DOAJ
collection DOAJ
language RU
topic intravenous immunoglobulin
therapy
mechanism
Immunologic diseases. Allergy
RC581-607
spellingShingle intravenous immunoglobulin
therapy
mechanism
Immunologic diseases. Allergy
RC581-607
V. A. Lazanovich
E. V. Prosekova
INTRAVENOUS IMMUNOGLOBULINS: MECHANISMS OF THERAPEUTIC EFFECTS
description Intravenous immunoglobulins (IVIG) are currently the most widely used immunobiological drug derived from donor blood. The IVIG preparations contain antibodies, mostly, of IgG class, obtained from plasma pools of 3,000 to 15,000 donors (over 1000 donors per lot, according to international standards and guidelines), being used for treatment of various diseases over four last decades. Initially, IVIG application wasaimed for immune support only in primary immunodeficiency states. However, recent clinical and experimental data show effectiveness of the IVIG in systemic and autoimmune diseases, immune-associated infertility and miscarriage. As well as in translantology, hematology and other fields of medicine. Their efficiency is associated with immunomodulatory effects. There is a growing number of publications bearing on this subject and elucidating possible mechanisms of therapeutic effects of IVIG, which are based on the latest basic and clinical research findings in this area. At the same time, much issues remain unclear and contradictory, and some data are mutually exclusive, thus prompting further studies and trials of IVIG preparations. The aim of this article is to summarize the known basic mechanisms of therapeutic effects, main results of recent research in this area,and potential clinical applications of IVIG in future.
format article
author V. A. Lazanovich
E. V. Prosekova
author_facet V. A. Lazanovich
E. V. Prosekova
author_sort V. A. Lazanovich
title INTRAVENOUS IMMUNOGLOBULINS: MECHANISMS OF THERAPEUTIC EFFECTS
title_short INTRAVENOUS IMMUNOGLOBULINS: MECHANISMS OF THERAPEUTIC EFFECTS
title_full INTRAVENOUS IMMUNOGLOBULINS: MECHANISMS OF THERAPEUTIC EFFECTS
title_fullStr INTRAVENOUS IMMUNOGLOBULINS: MECHANISMS OF THERAPEUTIC EFFECTS
title_full_unstemmed INTRAVENOUS IMMUNOGLOBULINS: MECHANISMS OF THERAPEUTIC EFFECTS
title_sort intravenous immunoglobulins: mechanisms of therapeutic effects
publisher SPb RAACI
publishDate 2014
url https://doaj.org/article/8ed4342c9bdc4d5fa4a83c4ced64c76c
work_keys_str_mv AT valazanovich intravenousimmunoglobulinsmechanismsoftherapeuticeffects
AT evprosekova intravenousimmunoglobulinsmechanismsoftherapeuticeffects
_version_ 1718422434161360896